Dawn Svoronos

Director at Xenon Pharmaceuticals · 4 reported transactions in 2 companies · latest report Sep 1, 2026

Their trades


Xenon PharmaceuticalsXENE	Exercised options $41.9K · 5,144 shares	Sep 1, 2026
Xenon PharmaceuticalsXENE	Shares withheld for tax $75.6K · 1,416 shares	Jun 1, 2026
Xenon PharmaceuticalsXENE	Exercised options — · 2,645 shares	Jun 1, 2026
Adverum BiotechnologiesADVM	Other — · 5,000 shares	Dec 9, 2025

Sep 1, 2026 · XENE

$41.9K

Shares withheld for taxXenon Pharmaceuticals

Jun 1, 2026 · XENE

$75.6K

Jun 1, 2026 · XENE

2,645

Dec 9, 2025 · ADVM

5,000

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Xenon Pharmaceuticals · 4 reported transactions in 2 companies · latest report Sep 1, 2026


Xenon PharmaceuticalsXENE	Exercised options $41.9K · 5,144 shares	Sep 1, 2026
Xenon PharmaceuticalsXENE	Shares withheld for tax $75.6K · 1,416 shares	Jun 1, 2026
Xenon PharmaceuticalsXENE	Exercised options — · 2,645 shares	Jun 1, 2026
Adverum BiotechnologiesADVM	Other — · 5,000 shares	Dec 9, 2025